AutekBio raises $1.1M for contract cell lines
Santa Clara, Calif.’s AutekBio, a Silicon Valley-Beijing hybrid that grows engineered cell lines for drug companies, raised $1.1 million. See our story in today’s daily briefing at VentureBeat Life Sciences.
Next Story: DFJ partners with Esprit in Europe, to form DFJ Esprit
Previous Story: Capnia names former Glaxo, Alza chief Ernest Mario as CEO
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.
VentureBeat Writers
- Matt Marshall, Editor-in-Chief
- Dean Takahashi, Lead Writer, GamesBeat
- Anthony Ha, Assistant Editor, VentureBeat
- Camille Ricketts, Lead Writer, GreenBeat
- Paul Boutin, Writer, VentureBeat
- Kim-Mai Cutler, Writer, VentureBeat
- Matthaus Krzykowski, Mobile Consultant & Coordinator
VentureBeat Start-Up Index
An index of the hottest startups, measured by trends in their traffic, news coverage, buzz and funding.